Jalil, Almirah A.

HRN: 23-23-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
CEFUROXIME 750MG (VIAL)
06/28/2023
07/04/2023
IVT
500mg
Q12
PCAP-C
Waiting Final Action 
06/28/2023
CEFUROXIME 750MG (VIAL)
06/28/2023
07/05/2023
IVT
375mg
Q8
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: